Human microsomal carbonyl reducing enzymes in the metabolism of xenobiotics: well-known and promising members of the SDR superfamily

References

• Agarwal, A. K., Monder, C., Eckstein, B., White, P. C. (1989). Cloning and expression of rat cDNA encoding corticosteroid 11 beta-dehydrogenase. J Biol Chem 264:18939–18943.
   PubMed Web of Science ®Google Scholar
• Andersson, S., Geissler, W. M., Patel, S., Wu, L. (1995). The molecular biology of androgenic 17 beta-hydroxysteroid dehydrogenases. J Steroid Biochem Mol Biol 53:37–39.
   PubMed Web of Science ®Google Scholar
• Atanasov, A. G., Nashev, L. G., Gelman, L., Legeza, B., Sack, R., Portmann, R., et al. (2008). Direct protein-protein interaction of 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the endoplasmic reticulum lumen. Biochim Biophys Acta 1783:1536–1543.
   PubMed Web of Science ®Google Scholar
• Atanasov, A. G., Nashev, L. G., Schweizer, R. A., Frick, C., Odermatt, A. (2004). Hexose-6-phosphate dehydrogenase determines the reaction direction of 11beta-hydroxysteroid dehydrogenase type 1 as an oxoreductase. FEBS Lett 571:129–133.
   PubMed Web of Science ®Google Scholar
• Banhegyi, G., Benedetti, A., Fulceri, R., Senesi, S. (2004). Cooperativity between 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the lumen of the endoplasmic reticulum. J Biol Chem 279:27017–27021.
   PubMed Web of Science ®Google Scholar
• Barski, O. A., Tipparaju, S. M., Bhatnagar, A. (2008). The aldo-keto reductase superfamily and its role in drug metabolism and detoxification. Drug Metab Rev 40:553–624.
   PubMed Web of Science ®Google Scholar
• Bauman, D. R., Steckelbroeck, S., Williams, M. V., Peehl, D. M., Penning, T. M. (2006). Identification of the major oxidative 3alpha-hydroxysteroid dehydrogenase in human prostate that converts 5alpha-androstane-3alpha,17beta-diol to 5alpha-dihydrotestosterone: a potential therapeutic target for androgen-dependent disease. Mol Endocrinol 20:444–458.
   PubMed Web of Science ®Google Scholar
• Belyaeva, O. V., Chetyrkin, S. V., Clark, A. L., Kostereva, N. V., SantaCruz, K. S., Chronwall, B. M., et al. (2007). Role of microsomal retinol/sterol dehydrogenase-like short-chain dehydrogenases/reductases in the oxidation and epimerization of 3alpha-hydroxysteroids in human tissues. Endocrinology 148:2148–2156.
   PubMed Web of Science ®Google Scholar
• Belyaeva, O. V., Chetyrkin, S. V., Kedishvili, N. Y. (2003a). Characterization of truncated mutants of human microsomal short-chain dehydrogenase/reductase RoDH-4. Chem Biol Interact 143–144:279–287.
   PubMed Web of Science ®Google Scholar
• Belyaeva, O. V., Kedishvili, N. Y. (2002). Human pancreas protein 2 (PAN2) has a retinal reductase activity and is ubiquitously expressed in human tissues. FEBS Lett 531:489–493.
   PubMed Web of Science ®Google Scholar
• Belyaeva, O. V., Korkina, O. V., Stetsenko, A. V., Kedishvili, N. Y. (2008). Human retinol dehydrogenase 13 (RDH13) is a mitochondrial short-chain dehydrogenase/reductase with a retinaldehyde reductase activity. FEBS J 275:138–147.
   PubMed Web of Science ®Google Scholar
• Belyaeva, O. V., Korkina, O. V., Stetsenko, A. V., Kim, T., Nelson, P. S., Kedishvili, N. Y. (2005). Biochemical properties of purified human retinol dehydrogenase 12 (RDH12): catalytic efficiency toward retinoids and C9 aldehydes and effects of cellular retinol-binding protein type I (CRBPI) and cellular retinaldehyde-binding protein (CRALBP) on the oxidation and reduction of retinoids. Biochemistry 44:7035–7047.
   PubMed Web of Science ®Google Scholar
• Belyaeva, O. V., Stetsenko, A. V., Nelson, P., Kedishvili, N. Y. (2003b). Properties of short-chain dehydrogenase/reductase RalR1: characterization of purified enzyme, its orientation in the microsomal membrane, and distribution in human tissues and cell lines. Biochemistry 42:14838–14845.
   PubMed Web of Science ®Google Scholar
• Bianchet, M. A., Erdemli, S. B., Amzel, L. M. (2008). Structure, function, and mechanism of cytosolic quinone reductases. Vitam Horm 78:63–84.
   PubMed Web of Science ®Google Scholar
• Biswas, M. G., Russell, D. W. (1997). Expression cloning and characterization of oxidative 17beta- and 3alpha-hydroxysteroid dehydrogenases from rat and human prostate. J Biol Chem 272:15959–15966.
   PubMed Web of Science ®Google Scholar
• Blum, A., Martin, H. J., Maser, E. (2000). Human 11beta-hydroxysteroid dehydrogenase 1/carbonyl reductase: recombinant expression in the yeast Pichia pastoris and Escherichia coli Toxicology 144:113–120.
   PubMed Web of Science ®Google Scholar
• Boehmer, A. L., Brinkmann, A. O., Sandkuijl, L. A., Halley, D. J., Niermeijer, M. F., Andersson, S., et al. (1999). 17Beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J Clin Endocrinol Metab 84:4713–4721.
   PubMed Web of Science ®Google Scholar
• Bray, J. E., Marsden, B. D., Oppermann, U. (2009). The human short-chain dehydrogenase/reductase (SDR) superfamily: a bioinformatics summary. Chem Biol Interact 178:99–109.
   PubMed Web of Science ®Google Scholar
• Breitling, R., Krazeisen, A., Moller, G., Adamski, J. (2001). 17beta-hydroxysteroid dehydrogenase type 7—an ancient 3-ketosteroid reductase of cholesterogenesis. Mol Cell Endocrinol 171:199–204.
   PubMed Web of Science ®Google Scholar
• Breyer-Pfaff, U., Martin, H. J., Ernst, M., Maser, E. (2004). Enantioselectivity of carbonyl reduction of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone by tissue fractions from human and rat and by enzymes isolated from human liver. Drug Metab Dispos 32:915–922.
   PubMed Web of Science ®Google Scholar
• Breyer-Pfaff, U., Nill, K. (2004). Carbonyl reduction of naltrexone and dolasetron by oxidoreductases isolated from human liver cytosol. J.Pharm.Pharmacol 56:1601–1606.
   PubMed Web of Science ®Google Scholar
• Bublitz, C., Lawler, C. A. (1987). The levels of nicotinamide nucleotides in liver microsomes and their possible significance to the function of hexose phosphate dehydrogenase. Biochem J 245:263–267.
   PubMed Web of Science ®Google Scholar
• Bujalska, I.J., Draper, N., Michailidou, Z., Tomlinson, J. W., White, P. C., Chapman, K. E., et al. (2005). Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1. J Mol Endocrinol 34:675–684.
   PubMed Web of Science ®Google Scholar
• Cerignoli, F., Guo, X., Cardinali, B., Rinaldi, C., Casaletto, J., Frati, L., et al. (2002). retSDR1, a short-chain retinol dehydrogenase/reductase, is retinoic acid-inducible and frequently deleted in human neuroblastoma cell lines. Cancer Res 62:1196–1204.
   PubMed Web of Science ®Google Scholar
• Chai, Z., Brereton, P., Suzuki, T., Sasano, H., Obeyesekere, V., Escher, G., et al. (2003). 17 beta-hydroxysteroid dehydrogenase type XI localizes to human steroidogenic cells. Endocrinology 144:2084–2091.
   PubMed Web of Science ®Google Scholar
• Chetyrkin, S. V., Belyaeva, O. V., Gough, W. H., Kedishvili, N. Y. (2001a). Characterization of a novel type of human microsomal 3alpha -hydroxysteroid dehydrogenase: unique tissue distribution and catalytic properties. J Biol Chem 276:22278–22286.
   PubMed Web of Science ®Google Scholar
• Chetyrkin, S. V., Hu, J., Gough, W. H., Dumaual, N., Kedishvili, N. Y. (2001b). Further characterization of human microsomal 3alpha-hydroxysteroid dehydrogenase. Arch Biochem Biophys 386:1–10.
   PubMed Web of Science ®Google Scholar
• Coleman, M. D. (2005). Human drug metabolism: an introduction. Chichester, UK: John Wiley & Sons, Ltd.
   Google Scholar
• Ding, X., Rose, M. J., McCaffery, I., Rossi, J., Paweletz, K., Hale, C., et al. (2009). Determination of prednisolone in human adipose tissue incubation medium using LC-MS/MS to support the measurement of 11beta-hydroxysteroid dehydrogenase activity. J Chromatogr B Analyt Technol Biomed Life Sci 877:1394–1401.
   PubMed Web of Science ®Google Scholar
• Draper, N., Stewart, P. M. (2005). 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action. J Endocrinol 186:251–271.
   PubMed Web of Science ®Google Scholar
• Draper, N., Walker, E. A., Bujalska, I. J., Tomlinson, J. W., Chalder, S. M., Arlt, W., et al. (2003). Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet 34:434–439.
   PubMed Web of Science ®Google Scholar
• Duan, W. R., Linzer, D. I., Gibori, G. (1996). Cloning and characterization of an ovarian-specific protein that associates with the short form of the prolactin receptor. J Biol Chem 271:15602–15607.
   PubMed Web of Science ®Google Scholar
• Duester, G. (1996). Involvement of alcohol dehydrogenase, short-chain dehydrogenase/reductase, aldehyde dehydrogenase, and cytochrome P450 in the control of retinoid signaling by activation of retinoic acid synthesis. Biochemistry 35:12221–12227.
   PubMed Web of Science ®Google Scholar
• Dzyakanchuk, A. A., Balazs, Z., Nashev, L. G., Amrein, K. E., Odermatt, A. (2009). 11beta-Hydroxysteroid dehydrogenase 1 reductase activity is dependent on a high ratio of NADPH/NADP(+) and is stimulated by extracellular glucose. Mol Cell Endocrinol 301:137–141.
   PubMed Web of Science ®Google Scholar
• Endo, S., Matsunaga, T., Kitade, Y., Ohno, S., Tajima, K., El-Kabbani, O., et al. (2008). Human carbonyl reductase 4 is a mitochondrial NADPH-dependent quinone reductase. Biochem Biophys Res Commun 377:1326–1330.
   PubMed Web of Science ®Google Scholar
• Eyles, D. W., Pond, S. M. (1992). Stereospecific reduction of haloperidol in human tissues. Biochem Pharmacol 44:867–871.
   PubMed Web of Science ®Google Scholar
• Fields, A. L., Soprano, D. R., Soprano, K. J. (2007). Retinoids in biological control and cancer. J Cell Biochem 102:886–898.
   PubMed Web of Science ®Google Scholar
• Forrest, G. L., Gonzalez, B. (2000). Carbonyl reductase. Chem Biol Interact 129:21–40.
   PubMed Web of Science ®Google Scholar
• Frick, C., Atanasov, A. G., Arnold, P., Ozols, J., Odermatt, A. (2004). Appropriate function of 11beta-hydroxysteroid dehydrogenase type 1 in the endoplasmic reticulum lumen is dependent on its N-terminal region sharing similar topological determinants with 50-kDa esterase. J Biol Chem 279:31131–31138.
   PubMed Web of Science ®Google Scholar
• Gallego, O., Belyaeva, O. V., Porte, S., Ruiz, F. X., Stetsenko, A. V., Shabrova, E. V., et al. (2006). Comparative functional analysis of human medium-chain dehydrogenases, short-chain dehydrogenases/reductases and aldo-keto reductases with retinoids. Biochem J 399:101–109.
   PubMed Web of Science ®Google Scholar
• Gathercole, L. L., Stewart, P. M. (2010). Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes. J Steroid Biochem Mol Biol 122:21–27.
   PubMed Web of Science ®Google Scholar
• Gibson, G. G., Sket, P. (2009). Introduction to drug metabolism, 3rd ed. London: Nelson Thornes.
   Google Scholar
• Gough, W. H., VanOoteghem, S., Sint, T., Kedishvili, N. Y. (1998). cDNA cloning and characterization of a new human microsomal NAD+-dependent dehydrogenase that oxidizes all-trans-retinol and 3alpha-hydroxysteroids. J Biol Chem 273:19778–19785.
   PubMed Web of Science ®Google Scholar
• Guengerich, F. P., Cai, H., McMahon, M., Hayes, J. D., Sutter, T. R., Groopman, J. D., et al. (2001). Reduction of aflatoxin B1 dialdehyde by rat and human aldo-keto reductases. Chem Res Toxicol 14:727–737.
   PubMed Web of Science ®Google Scholar
• Haeseleer, F., Huang, J., Lebioda, L., Saari, J. C., Palczewski, K. (1998). Molecular characterization of a novel short-chain dehydrogenase/reductase that reduces all-trans-retinal. J Biol Chem 273:21790–21799.
   PubMed Web of Science ®Google Scholar
• Haeseleer, F., Jang, G. F., Imanishi, Y., Driessen, C. A., Matsumura, M., Nelson, P. S., et al. (2002). Dual-substrate specificity short chain retinol dehydrogenases from the vertebrate retina. J Biol Chem 277:45537–45546.
   PubMed Web of Science ®Google Scholar
• Haeseleer, F., Palczewski, K. (2000). Short-chain dehydrogenases/reductases in retina. Methods Enzymol 316:372–383.
   PubMed Web of Science ®Google Scholar
• Hammer, F., Stewart, P. M. (2006). Cortisol metabolism in hypertension. Best Pract Res Clin Endocrinol Metab 20:337–353.
   PubMed Web of Science ®Google Scholar
• Hennebert, O., Chalbot, S., Alran, S., Morfin, R. (2007a). Dehydroepiandrosterone 7alpha-hydroxylation in human tissues: possible interference with type 1 11beta-hydroxysteroid dehydrogenase-mediated processes. J Steroid Biochem Mol Biol 104:326–333.
   PubMed Web of Science ®Google Scholar
• Hennebert, O., Le, M. S., Pernelle, C., Morfin, R. (2007b). 5Alpha-androstane-3beta,7alpha,17beta-triol, and 5alpha-androstane-3beta,7beta,17beta-triol as substrates for the human 11beta-hydroxysteroid dehydrogenase type 1. Steroids 72:855–864.
   PubMed Web of Science ®Google Scholar
• Hennebert, O., Montes, M., Favre-Reguillon, A., Chermette, H., Ferroud, C., Morfin, R. (2009). Epimerase activity of the human 11beta-hydroxysteroid dehydrogenase type 1 on 7-hydroxylated C19-steroids. J Steroid Biochem Mol Biol 114:57–63.
   PubMed Web of Science ®Google Scholar
• Hoffmann, F., Maser, E. (2007). Carbonyl reductases and pluripotent hydroxysteroid dehydrogenases of the short-chain dehydrogenase/reductase superfamily. Drug Metab Rev 39:87–144.
   PubMed Web of Science ®Google Scholar
• Horiguchi, Y., Araki, M., Motojima, K. (2008). 17beta-Hydroxysteroid dehydrogenase type 13 is a liver-specific lipid droplet-associated protein. Biochem Biophys Res Commun 370:235–238.
   PubMed Web of Science ®Google Scholar
• Hosfield, D. J., Wu, Y., Skene, R. J., Hilgers, M., Jennings, A., Snell, G. P., et al. (2005). Conformational flexibility in crystal structures of human 11beta-hydroxysteroid dehydrogenase type I provide insights into glucocorticoid interconversion and enzyme regulation. J Biol Chem 280:4639–4648.
   PubMed Web of Science ®Google Scholar
• Huang, C., Wan, B., Gao, B., Hexige, S., Yu, L. (2009). Isolation and characterization of novel human short-chain dehydrogenase/reductase SCDR10B which is highly expressed in the brain and acts as hydroxysteroid dehydrogenase. Acta Biochim Pol 56:279–289.
   PubMed Web of Science ®Google Scholar
• Huang, X. F., Luu-The, V. (2000). Molecular characterization of a first human 3(alpha-->beta)-hydroxysteroid epimerase. J Biol Chem 275:29452–29457.
   PubMed Web of Science ®Google Scholar
• Huang, X. F., Luu-The, V. (2001). Modulation of the androgenic response by recombinant human 11-cis retinol dehydrogenase. J Steroid Biochem Mol Biol 77:129–133.
   PubMed Web of Science ®Google Scholar
• Hult, M., Elleby, B., Shafqat, N., Svensson, S., Rane, A., Jornvall, H., et al. (2004). Human and rodent type 1 11beta-hydroxysteroid dehydrogenases are 7beta-hydroxycholesterol dehydrogenases involved in oxysterol metabolism. Cell Mol Life Sci 61:992–999.
   PubMed Web of Science ®Google Scholar
• Hult, M., Nobel, C. S., Abrahmsen, L., Nicoll-Griffith, D. A., Jornvall, H., Oppermann, U. C. (2001). Novel enzymological profiles of human 11beta-hydroxysteroid dehydrogenase type 1. Chem Biol Interact 130–132:805–814.
   PubMed Web of Science ®Google Scholar
• Hult, M., Shafqat, N., Elleby, B., Mitschke, D., Svensson, S., Forsgren, M., et al. (2006). Active site variability of type 1 11beta-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons. Mol Cell Endocrinol 248:26–33.
   PubMed Web of Science ®Google Scholar
• Ito, K., Utsunomiya, H., Suzuki, T., Saitou, S., Akahira, J., Okamura, K., et al. (2006). 17Beta-hydroxysteroid dehydrogenases in human endometrium and its disorders. Mol Cell Endocrinol 248:136–140.
   PubMed Web of Science ®Google Scholar
• Jaiswal, A. K. (2000). Regulation of genes encoding NAD(P)H:quinone oxidoreductases. Free Radic Biol Med 29:254–262.
   PubMed Web of Science ®Google Scholar
• Jansson, A. (2009). 17Beta-hydroxysteroid dehydrogenase enzymes and breast cancer. J Steroid Biochem Mol Biol 114:64–67.
   PubMed Web of Science ®Google Scholar
• Jansson, A., Gunnarsson, C., Stal, O. (2006). Proliferative responses to altered 17beta-hydroxysteroid dehydrogenase (17HSD) type 2 expression in human breast cancer cells are dependent on endogenous expression of 17HSD type 1 and the oestradiol receptors. Endocr Relat Cancer 13:875–884.
   PubMed Web of Science ®Google Scholar
• Jette, C., Peterson, P. W., Sandoval, I. T., Manos, E. J., Hadley, E., Ireland, C. M., et al. (2004). The tumor suppressor adenomatous polyposis coli and caudal related homeodomain protein regulate expression of retinol dehydrogenase L. J Biol Chem 279:34397–34405.
   PubMed Web of Science ®Google Scholar
• Jez, J. M., Flynn, T. G., Penning, T. M. (1997). A nomenclature system for the aldo-keto reductase superfamily. Adv Exp Med Biol 414:579–600.
   PubMedGoogle Scholar
• Jornvall, H., Persson, B., Krook, M., Atrian, S., Gonzalez-Duarte, R., Jeffery, J., et al. (1995). Short-chain dehydrogenases/reductases (SDR). Biochemistry 34:6003–6013.
   PubMed Web of Science ®Google Scholar
• Kallberg, Y., Oppermann, U., Persson, B. (2010). Classification of the short-chain dehydrogenase/reductase superfamily using hidden Markov models. FEBS J 277:2375–2386.
   PubMed Web of Science ®Google Scholar
• Kassner, N., Huse, K., Martin, H. J., Godtel-Armbrust, U., Metzger, A., Meineke, I., et al. (2008). Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab Dispos 36:2113–2120.
   PubMed Web of Science ®Google Scholar
• Kasus-Jacobi, A., Ou, J., Bashmakov, Y. K., Shelton, J. M., Richardson, J. A., Goldstein, J. L., et al. (2003). Characterization of mouse short-chain aldehyde reductase (SCALD), an enzyme regulated by sterol regulatory element-binding proteins. J Biol Chem 278:32380–32389.
   PubMed Web of Science ®Google Scholar
• Kasus-Jacobi, A., Ou, J., Birch, D. G., Locke, K. G., Shelton, J. M., Richardson, J. A., et al. (2005). Functional characterization of mouse RDH11 as a retinol dehydrogenase involved in dark adaptation in vivo. J Biol Chem 280:20413–20420.
   PubMed Web of Science ®Google Scholar
• Kavanagh, K. L., Jornvall, H., Persson, B., Oppermann, U. (2008). Medium- and short-chain dehydrogenase/reductase gene and protein families: the SDR superfamily: functional and structural diversity within a family of metabolic and regulatory enzymes. Cell Mol.Life Sci 65:3895–3906.
   PubMed Web of Science ®Google Scholar
• Kedishvili, N. Y. (2002). Multifunctional nature of human retinol dehydrogenases. Curr Org Chem 6:1247–1257.
   Web of Science ®Google Scholar
• Kedishvili, N. Y., Chumakova, O. V., Chetyrkin, S. V., Belyaeva, O. V., Lapshina, E. A., Lin, D. W., et al. (2002). Evidence that the human gene for prostate short-chain dehydrogenase/reductase (PSDR1) encodes a novel retinal reductase (RalR1). J Biol Chem 277:28909–28915.
   PubMed Web of Science ®Google Scholar
• Keller, B., Adamski, J. (2007). RDH12, a retinol dehydrogenase causing Leber’s congenital amaurosis, is also involved in steroid metabolism. J Steroid Biochem Mol Biol 104:190–194.
   PubMed Web of Science ®Google Scholar
• Kenneke, J. F., Mazur, C. S., Kellock, K. A., Overmyer, J. P. (2009). Mechanistic approach to understanding the toxicity of the azole fungicide triadimefon to a nontarget aquatic insect and implications for exposure assessment. Environ Sci Technol 43:5507–5513.
   PubMed Web of Science ®Google Scholar
• Khan, N., Sharma, K. K., Andersson, S., Auchus, R. J. (2004). Human 17beta-hydroxysteroid dehydrogenases types 1, 2, and 3 catalyze bi-directional equilibrium reactions, rather than unidirectional metabolism, in HEK-293 cells. Arch Biochem Biophys 429:50–59.
   PubMed Web of Science ®Google Scholar
• Kowalik, D., Haller, F., Adamski, J., Moeller, G. (2009). In search for function of two human orphan SDR enzymes: hydroxysteroid dehydrogenase like 2 (HSDL2) and short-chain dehydrogenase/reductase-orphan (SDR-O). J Steroid Biochem Mol Biol 117:117–124.
   PubMed Web of Science ®Google Scholar
• Krazeisen, A., Breitling, R., Imai, K., Fritz, S., Moller, G., Adamski, J. (1999). Determination of cDNA, gene structure, and chromosomal localization of the novel human 17beta-hydroxysteroid dehydrogenase type 7(1). FEBS Lett 460:373–379.
   PubMed Web of Science ®Google Scholar
• Kudo, S., Ishizaki, T. (1999). Pharmacokinetics of haloperidol: an update. Clin Pharmacokinet 37:435–456.
   PubMed Web of Science ®Google Scholar
• Labrie, F., Luu-The, V., Lin, S. X., Labrie, C., Simard, J., Breton, R., et al. (1997). The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology. Steroids 62:148–158.
   PubMed Web of Science ®Google Scholar
• Labrie, F., Luu-The, V., Lin, S. X., Simard, J., Labrie, C. (2000a). Role of 17 beta-hydroxysteroid dehydrogenases in sex steroid formation in peripheral intracrine tissues. Trends Endocrinol Metab 11:421–427.
   PubMed Web of Science ®Google Scholar
• Labrie, F., Luu-The, V., Lin, S. X., Simard, J., Labrie, C., El-Alfy, M., et al. (2000b). Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease. J Mol Endocrinol 25:1–16.
   PubMed Web of Science ®Google Scholar
• Lapshina, E. A., Belyaeva, O. V., Chumakova, O. V., Kedishvili, N. Y. (2003a). Differential recognition of the free versus bound retinol by human microsomal retinol/sterol dehydrogenases: characterization of the holo-CRBP dehydrogenase activity of RoDH-4. Biochemistry 42:776–784.
   PubMed Web of Science ®Google Scholar
• Lapshina, E. A., Belyaeva, O. V., Chumakova, O. V., Kedishvili, N. Y. (2003b). Differential recognition of the free versus bound retinol by human microsomal retinol/sterol dehydrogenases: characterization of the holo-CRBP dehydrogenase activity of RoDH-4. Biochemistry 42:776–784.
   PubMed Web of Science ®Google Scholar
• Lee, S. A., Belyaeva, O. V., Kedishvili, N. Y. (2008). Effect of lipid peroxidation products on the activity of human retinol dehydrogenase 12 (RDH12) and retinoid metabolism. Biochim Biophys Acta 1782:421–425.
   PubMed Web of Science ®Google Scholar
• Liden, M., Eriksson, U. (2006). Understanding retinol metabolism: structure and function of retinol dehydrogenases. J Biol Chem 281:13001–13004.
   PubMed Web of Science ®Google Scholar
• Liden, M., Tryggvason, K., Eriksson, U. (2003). Structure and function of retinol dehydrogenases of the short chain dehydrogenase/reductase family. Mol Aspects Med 24:403–409.
   PubMed Web of Science ®Google Scholar
• Liden, M., Tryggvason, K., Eriksson, U. (2005). The C-terminal region of cis-retinol/androgen dehydrogenase 1 (CRAD1) confers ER localization and in vivo enzymatic function. Exp Cell Res 311:205–217.
   PubMed Web of Science ®Google Scholar
• Lin, B., White, J. T., Ferguson, C., Wang, S., Vessella, R., Bumgarner, R., et al. (2001). Prostate short-chain dehydrogenase reductase 1 (PSDR1): a new member of the short-chain steroid dehydrogenase/reductase family highly expressed in normal and neoplastic prostate epithelium. Cancer Res 61:1611–1618.
   PubMed Web of Science ®Google Scholar
• Liu, S., Huang, C., Li, D., Ren, W., Zhang, H., Qi, M., et al. (2007). Molecular cloning and expression analysis of a new gene for short-chain dehydrogenase/reductase 9. Acta Biochim Pol 54:213–218.
   PubMed Web of Science ®Google Scholar
• Lukacik, P., Kavanagh, K. L., Oppermann, U. (2006). Structure and function of human 17beta-hydroxysteroid dehydrogenases. Mol Cell Endocrinol 248:61–71.
   PubMed Web of Science ®Google Scholar
• Luu-The, V. (2001). Analysis and characteristics of multiple types of human 17beta-hydroxysteroid dehydrogenase. J Steroid Biochem Mol Biol 76:143–151.
   PubMed Web of Science ®Google Scholar
• Luu-The, V., Belanger, A., Labrie, F. (2008). Androgen biosynthetic pathways in the human prostate. Best Pract Res Clin Endocrinol Metab 22:207–221.
   PubMed Web of Science ®Google Scholar
• Luu-The, V., Tremblay, P., Labrie, F. (2006). Characterization of type 12 17beta-hydroxysteroid dehydrogenase, an isoform of type 3 17beta-hydroxysteroid dehydrogenase responsible for estradiol formation in women. Mol Endocrinol 20:437–443.
   PubMed Web of Science ®Google Scholar
• Maeda, A., Maeda, T., Imanishi, Y., Kuksa, V., Alekseev, A., Bronson, J. D., et al. (2005). Role of photoreceptor-specific retinol dehydrogenase in the retinoid cycle in vivo. J Biol Chem 280:18822–18832.
   PubMed Web of Science ®Google Scholar
• Marchette, L. D., Thompson, D. A., Kravtsova, M., Ngansop, T. N., Mandal, M. N., Kasus-Jacobi, A. (2010). Retinol dehydrogenase 12 detoxifies 4-hydroxynonenal in photoreceptor cells. Free Radic Biol Med 48:16–25.
   PubMed Web of Science ®Google Scholar
• Marijanovic, Z., Laubner, D., Moller, G., Gege, C., Husen, B., Adamski, J., et al. (2003). Closing the gap: identification of human 3-ketosteroid reductase, the last unknown enzyme of mammalian cholesterol biosynthesis. Mol Endocrinol 17:1715–1725.
   PubMed Web of Science ®Google Scholar
• Markova, N. G., Pinkas-Sarafova, A., Simon, M. (2006). A metabolic enzyme of the short-chain dehydrogenase/reductase superfamily may moonlight in the nucleus as a repressor of promoter activity. J Invest Dermatol 126:2019–2031.
   PubMed Web of Science ®Google Scholar
• Martin, H. J., Breyer-Pfaff, U., Wsol, V., Venz, S., Block, S., Maser, E. (2006). Purification and characterization of akr1b10 from human liver: role in carbonyl reduction of xenobiotics. Drug Metab Dispos 34:464–470.
   PubMed Web of Science ®Google Scholar
• Maser, E. (2004). Significance of reductases in the detoxification of the tobacco-specific carcinogen NNK. Trends Pharmacol Sci 25:235–237.
   PubMed Web of Science ®Google Scholar
• Maser, E., Bannenberg, G. (1994a). 11 beta-hydroxysteroid dehydrogenase mediates reductive metabolism of xenobiotic carbonyl compounds. Biochem Pharmacol 47:1805–1812.
   PubMed Web of Science ®Google Scholar
• Maser, E., Bannenberg, G. (1994b). The purification of 11 beta-hydroxysteroid dehydrogenase from mouse liver microsomes. J Steroid Biochem Mol Biol 48:257–263.
   PubMed Web of Science ®Google Scholar
• Maser, E., Oppermann, U. C. (1997). Role of type-1 11beta-hydroxysteroid dehydrogenase in detoxification processes. Eur J Biochem 249:365–369.
   PubMedGoogle Scholar
• Maser, E., Volker, B., Friebertshauser, J. (2002). 11 Beta-hydroxysteroid dehydrogenase type 1 from human liver: dimerization and enzyme cooperativity support its postulated role as glucocorticoid reductase. Biochemistry 41:2459–2465.
   PubMed Web of Science ®Google Scholar
• Maser, E., Wsol, V., Martin, H. J. (2006). 11Beta-hydroxysteroid dehydrogenase type 1: purification from human liver and characterization as carbonyl reductase of xenobiotics. Mol Cell Endocrinol 248:34–37.
   PubMed Web of Science ®Google Scholar
• Masuzaki, H., Flier, J. S. (2003). Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)—a promising drug target for the treatment of metabolic syndrome. Curr Drug Targets Immune Endocr Metabol Disord 3:255–262.
   PubMedGoogle Scholar
• Matsunaga, T., Endo, S., Maeda, S., Ishikura, S., Tajima, K., Tanaka, N., et al. (2008). Characterization of human DHRS4: an inducible short-chain dehydrogenase/reductase enzyme with 3beta-hydroxysteroid dehydrogenase activity. Arch Biochem Biophys 477:339–347.
   PubMed Web of Science ®Google Scholar
• Matsunaga, T., Shintani, S., Hara, A. (2006). Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. Drug Metab Pharmacokinet 21:1–18.
   PubMed Web of Science ®Google Scholar
• Meier, M., Tokarz, J., Haller, F., Mindnich, R., Adamski, J. (2009). Human and zebrafish hydroxysteroid dehydrogenase like 1 (HSDL1) proteins are inactive enzymes but conserved among species. Chem Biol Interact 178:197–205.
   PubMed Web of Science ®Google Scholar
• Mindnich, R., Haller, F., Halbach, F., Moeller, G., Hrabe de, A. M., Adamski, J. (2005). Androgen metabolism via 17beta-hydroxysteroid dehydrogenase type 3 in mammalian and non-mammalian vertebrates: comparison of the human and the zebrafish enzyme. J Mol Endocrinol 35:305–316.
   PubMed Web of Science ®Google Scholar
• Mindnich, R., Moller, G., Adamski, J. (2004). The role of 17 beta-hydroxysteroid dehydrogenases. Mol Cell Endocrinol 218:7–20.
   PubMed Web of Science ®Google Scholar
• Miura, T., Nishinaka, T., Terada, T. (2008). Different functions between human monomeric carbonyl reductase 3 and carbonyl reductase 1. Mol Cell Biochem 315:113–121.
   PubMed Web of Science ®Google Scholar
• Moeller, G., Adamski, J. (2006). Multifunctionality of human 17beta-hydroxysteroid dehydrogenases. Mol Cell Endocrinol 248:47–55.
   PubMed Web of Science ®Google Scholar
• Moeller, G., Adamski, J. (2009). Integrated view on 17beta-hydroxysteroid dehydrogenases. Mol Cell Endocrinol 301:7–19.
   PubMed Web of Science ®Google Scholar
• Moon, Y. A., Horton, J. D. (2003). Identification of two mammalian reductases involved in the two-carbon fatty acyl elongation cascade. J Biol Chem 278:7335–7343.
   PubMed Web of Science ®Google Scholar
• Motojima, K., Hirai, T. (2006). Peroxisome proliferator-activated receptor alpha plays a vital role in inducing a detoxification system against plant compounds with crosstalk with other xenobiotic nuclear receptors. FEBS J 273:292–300.
   PubMed Web of Science ®Google Scholar
• Nadauld, L. D., Phelps, R., Moore, B. C., Eisinger, A., Sandoval, I. T., Chidester, S., et al. (2006). Adenomatous polyposis coli control of C-terminal binding protein-1 stability regulates expression of intestinal retinol dehydrogenases. J Biol Chem 281:37828–37835.
   PubMed Web of Science ®Google Scholar
• Nagasaki, S., Miki, Y., Akahira, J., Suzuki, T., Sasano, H. (2009). 17beta-hydroxysteroid dehydrogenases in human breast cancer. Ann N Y Acad Sci 1155:25–32.
   PubMed Web of Science ®Google Scholar
• Nicklasson, M., Bjorkman, S., Roth, B., Jonsson, M., Hoglund, P. (2002). Stereoselective metabolism of pentoxifylline in vitro and in vivo in humans. Chirality 14:643–652.
   PubMed Web of Science ®Google Scholar
• Nordling, E., Jornvall, H., Persson, B. (2002). Medium-chain dehydrogenases/reductases (MDR). Family characterizations including genome comparisons and active site modeling. Eur J Biochem 269:4267–4276.
   Google Scholar
• Novotna, R., Wsol, V., Xiong, G., Maser, E. (2008). Inactivation of the anticancer drugs doxorubicin and oracin by aldo-keto reductase (AKR) 1C3. Toxicol Lett 181:1–6.
   PubMed Web of Science ®Google Scholar
• Odermatt, A., Arnold, P., Stauffer, A., Frey, B. M., Frey, F. J. (1999). The N-terminal anchor sequences of 11beta-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membrane. J Biol Chem 274:28762–28770.
   PubMed Web of Science ®Google Scholar
• Odermatt, A., Atanasov, A. G., Balazs, Z., Schweizer, R. A., Nashev, L. G., Schuster, D., et al. (2006). Why is 11beta-hydroxysteroid dehydrogenase type 1 facing the endoplasmic reticulum lumen? Physiological relevance of the membrane topology of 11beta-HSD1. Mol Cell Endocrinol 248:15–23.
   PubMed Web of Science ®Google Scholar
• Ohnesorg, T., Adamski, J. (2006). Analysis of the 5′ flanking regions of human and murine HSD17B7: identification of a cholesterol dependent enhancer region. Mol Cell Endocrinol 248:164–167.
   PubMed Web of Science ®Google Scholar
• Ohnesorg, T., Keller, B., Hrabe de, A. M., Adamski, J. (2006). Transcriptional regulation of human and murine 17beta-hydroxysteroid dehydrogenase type-7 confers its participation in cholesterol biosynthesis. J Mol Endocrinol 37:185–197.
   PubMed Web of Science ®Google Scholar
• Oppermann, U. (2007). Carbonyl reductases: the complex relationships of mammalian carbonyl- and quinone-reducing enzymes and their role in physiology. Annu Rev Pharmacol Toxicol 47:293–322.
   PubMed Web of Science ®Google Scholar
• Oppermann, U., Filling, C., Hult, M., Shafqat, N., Wu, X., Lindh, M., et al. (2003). Short-chain dehydrogenases/reductases (SDR): the 2002 update. Chem Biol Interact 143–144:247–253.
   PubMed Web of Science ®Google Scholar
• Oppermann, U. C., Maser, E. (2000). Molecular and structural aspects of xenobiotic carbonyl metabolizing enzymes. Role of reductases and dehydrogenases in xenobiotic phase I reactions. Toxicology 144:71–81.
   Google Scholar
• Pares, X., Farres, J., Kedishvili, N., Duester, G. (2008). Medium- and short-chain dehydrogenase/reductase gene and protein families: medium-chain and short-chain dehydrogenases/reductases in retinoid metabolism. Cell Mol Life Sci 65:3936–3949.
   PubMed Web of Science ®Google Scholar
• Penning, T. M., Byrns, M. C. (2009). Steroid hormone transforming aldo-keto reductases and cancer. Ann N Y Acad Sci 1155:33–42.
   PubMed Web of Science ®Google Scholar
• Persson, B., Hedlund, J., Jornvall, H. (2008). Medium- and short-chain dehydrogenase/reductase gene and protein families: the MDR superfamily. Cell Mol Life Sci 65:3879–3894.
   PubMedGoogle Scholar
• Persson, B., Kallberg, Y., Bray, J. E., Bruford, E., Dellaporta, S. L., Favia, A. D., et al. (2009). The SDR (short-chain dehydrogenase/reductase and related enzymes) nomenclature initiative. Chem Biol Interact 178:94–98.
   PubMed Web of Science ®Google Scholar
• Pilka, E. S., Niesen, F. H., Lee, W. H., El-Hawari, Y., Dunford, J. E., Kochan, G., et al. (2009). Structural basis for substrate specificity in human monomeric carbonyl reductases. PLoS One 4:e7113.
   PubMed Web of Science ®Google Scholar
• Poirier, D. (2003). Inhibitors of 17 beta-hydroxysteroid dehydrogenases. Curr Med Chem 10:453–477.
   PubMed Web of Science ®Google Scholar
• Poirier, D. (2009). Advances in development of inhibitors of 17beta hydroxysteroid dehydrogenases. Anticancer Agents Med Chem 9:642–660.
   PubMed Web of Science ®Google Scholar
• Porter, S. J., Somogyi, A. A., White, J. M. (2000). Kinetics and inhibition of the formation of 6beta-naltrexol from naltrexone in human liver cytosol. Br J Clin Pharmacol 50:465–471.
   PubMed Web of Science ®Google Scholar
• Prasad, P. V., Arumugam, R., Willman, M., Ge, R. S., Sitruk-Ware, R., Kumar, N. (2009). Distribution, metabolism, and excretion of a synthetic androgen 7alpha-methyl-19-nortestosterone, a potential male-contraceptive. Steroids 74:121–131.
   PubMed Web of Science ®Google Scholar
• Puranen, T. J., Kurkela, R. M., Lakkakorpi, J. T., Poutanen, M. H., Itaranta, P. V., Melis, J. P., et al. (1999). Characterization of molecular and catalytic properties of intact and truncated human 17beta-hydroxysteroid dehydrogenase type 2 enzymes: intracellular localization of the wild-type enzyme in the endoplasmic reticulum. Endocrinology 140:3334–3341.
   PubMed Web of Science ®Google Scholar
• Rattner, A., Smallwood, P. M., Nathans, J. (2000). Identification and characterization of all-trans-retinol dehydrogenase from photoreceptor outer segments, the visual cycle enzyme that reduces all-trans-retinal to all-trans-retinol. J Biol Chem 275:11034–11043.
   PubMed Web of Science ®Google Scholar
• Rekka, E. A., Soldan, M., Belai, I., Netter, K. J., Maser, E. (1996). Biotransformation and detoxification of insecticidal metyrapone analogues by carbonyl reduction in the human liver. Xenobiotica 26:1221–1229.
   PubMed Web of Science ®Google Scholar
• Robinzon, B., Prough, R.. (2009). A novel NADP(+)-dependent dehydrogenase activity for 7alpha/beta- and 11beta-hydroxysteroids in human liver nuclei: a third 11beta-hydroxysteroid dehydrogenase. Arch Biochem Biophys 486:170–176.
   PubMed Web of Science ®Google Scholar
• Rosemond, M. J., Walsh, J. S. (2004). Human carbonyl reduction pathways and a strategy for their study in vitro. Drug Metab Rev 36:335–361.
   PubMed Web of Science ®Google Scholar
• Sakurai, N., Miki, Y., Suzuki, T., Watanabe, K., Narita, T., Ando, K., et al. (2006). Systemic distribution and tissue localizations of human 17beta-hydroxysteroid dehydrogenase type 12. J Steroid Biochem Mol Biol 99:174–181.
   PubMed Web of Science ®Google Scholar
• Sasano, H., Suzuki, T., Miki, Y., Moriya, T. (2008). Intracrinology of estrogens and androgens in breast carcinoma. J Steroid Biochem Mol Biol 108:181–185.
   PubMed Web of Science ®Google Scholar
• Schweizer, R. A., Zurcher, M., Balazs, Z., Dick, B., Odermatt, A. (2004). Rapid hepatic metabolism of 7-ketocholesterol by 11beta-hydroxysteroid dehydrogenase type 1: species-specific differences between the rat, human, and hamster enzyme. J Biol Chem 279:18415–18424.
   PubMed Web of Science ®Google Scholar
• Seddon, A. M., Curnow, P., Booth, P. J. (2004). Membrane proteins, lipids, and detergents: not just a soap opera. Biochim Biophys Acta 1666:105–117.
   PubMed Web of Science ®Google Scholar
• Seliskar, M., Rozman, D. (2007). Mammalian cytochromes P450—importance of tissue specificity. Biochim Biophys Acta 1770:458–466.
   PubMed Web of Science ®Google Scholar
• Shafqat, N., Shafqat, J., Eissner, G., Marschall, H. U., Tryggvason, K., Eriksson, U., et al. (2006). Hep27, a member of the short-chain dehydrogenase/reductase family, is an NADPH-dependent dicarbonyl reductase expressed in vascular endothelial tissue. Cell Mol Life Sci 63:1205–1213.
   PubMed Web of Science ®Google Scholar
• Skalova, L., Nobilis, M., Szotakova, B., Kondrova, E., Savlik, M., Wsol, V., et al. (2002). Carbonyl reduction of the potential cytostatic drugs benfluron and 3,9-dimethoxybenfluron in human in vitro. Biochem Pharmacol 64:297–305.
   PubMed Web of Science ®Google Scholar
• Skarydova, L., Skarka, A., Novotna, R., Zivna, L., Martin, H. J., Wsol, V., et al. (2009). Partial purification and characterization of a new human membrane-bound carbonyl reductase playing a role in the deactivation of the anticancer drug oracin. Toxicology 264:52–60.
   PubMed Web of Science ®Google Scholar
• Song, D., Liu, G., Luu-The, V., Zhao, D., Wang, L., Zhang, H., et al. (2006). Expression of aromatase and 17beta-hydroxysteroid dehydrogenase types 1, 7, and 12 in breast cancer. An immunocytochemical study. J Steroid Biochem Mol Biol 101:136–144.
   PubMed Web of Science ®Google Scholar
• Soref, C. M., Di, Y. P., Hayden, L., Zhao, Y. H., Satre, M. A., Wu, R. (2001). Characterization of a novel airway epithelial cell-specific short chain alcohol dehydrogenase/reductase gene whose expression is up-regulated by retinoids and is involved in the metabolism of retinol. J Biol Chem 276:24194–24202.
   PubMed Web of Science ®Google Scholar
• Soronen, P., Laiti, M., Torn, S., Harkonen, P., Patrikainen, L., Li, Y., et al. (2004). Sex steroid hormone metabolism and prostate cancer. J Steroid Biochem Mol Biol 92:281–286.
   PubMed Web of Science ®Google Scholar
• Stoffel-Wagner, B., Watzka, M., Steckelbroeck, S., Schramm, J., Bidlingmaier, J. F., Klingmuller, D. (1999). Expression of 17beta-hydroxysteroid dehydrogenase types 1, 2, 3, and 4 in the human temporal lobe. J Endocrinol 160:119–126.
   PubMed Web of Science ®Google Scholar
• Stulnig, T. M., Waldhausl, W. (2004). 11beta-Hydroxysteroid dehydrogenase type 1 in obesity and type 2 diabetes. Diabetologia 47:1–11.
   PubMed Web of Science ®Google Scholar
• Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., et al. (2004). 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 25:831–866.
   PubMed Web of Science ®Google Scholar
• Torn, S., Nokelainen, P., Kurkela, R., Pulkka, A., Menjivar, M., Ghosh, S., et al. (2003). Production, purification, and functional analysis of recombinant human and mouse 17beta-hydroxysteroid dehydrogenase type 7. Biochem Biophys Res Commun 305:37–45.
   PubMed Web of Science ®Google Scholar
• Upadhyaya, P., Carmella, S. G., Guengerich, F. P., Hecht, S. S. (2000). Formation and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers in vitro in mouse, rat, and human tissues. Carcinogenesis 21:1233–1238.
   PubMed Web of Science ®Google Scholar
• Vasiliou, V., Pappa, A., Petersen, D. R. (2000). Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism. Chem Biol Interact 129:1–19.
   PubMed Web of Science ®Google Scholar
• Veech, R. L., Eggleston, L. V., Krebs, H. A. (1969). The redox state of free nicotinamide-adenine dinucleotide phosphate in the cytoplasm of rat liver. Biochem J 115:609–619.
   PubMed Web of Science ®Google Scholar
• Walker, E. A., Stewart, P. M. (2003). 11beta-hydroxysteroid dehydrogenase: unexpected connections. Trends Endocrinol Metab 14:334–339.
   PubMed Web of Science ®Google Scholar
• Wamil, M., Seckl, J. R. (2007). Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target. Drug Discov Today 12:504–520.
   PubMed Web of Science ®Google Scholar
• Wang, J., Chai, X., Eriksson, U., Napoli, J. L. (1999). Activity of human 11-cis-retinol dehydrogenase (Rdh5) with steroids and retinoids and expression of its mRNA in extra-ocular human tissue. Biochem J 338:23–27.
   PubMed Web of Science ®Google Scholar
• Woolf, T. F. (1999). Handbook of drug metabolism. New York: Marcel Dekker.
   Google Scholar
• Wsol, V., Szotakova, B., Skalova, L., Maser, E. (2003). Stereochemical aspects of carbonyl reduction of the original anticancer drug oracin by mouse liver microsomes and purified 11beta-hydroxysteroid dehydrogenase type 1. Chem Biol Interact 143–144:459–468.
   PubMed Web of Science ®Google Scholar
• Wsol, V., Szotakova, B., Skalova, L., Maser, E. (2004). The novel anticancer drug oracin: different stereospecificity and cooperativity for carbonyl reduction by purified human liver 11beta-hydroxysteroid dehydrogenase type 1. Toxicology 197:253–261.
   PubMed Web of Science ®Google Scholar
• Wu, B. X., Moiseyev, G., Chen, Y., Rohrer, B., Crouch, R. K., Ma, J. X. (2004). Identification of RDH10, an all-trans retinol dehydrogenase, in retinal Muller cells. Invest Ophthalmol Vis Sci 45:3857–3862.
   PubMed Web of Science ®Google Scholar
• Yang, S., Fang, Z., Gurates, B., Tamura, M., Miller, J., Ferrer, K., et al. (2001). Stromal PRs mediate induction of 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrial epithelium: a paracrine mechanism for inactivation of E2. Mol Endocrinol 15:2093–2105.
   PubMed Web of Science ®Google Scholar
• Yokoi, Y., Horiguchi, Y., Araki, M., Motojima, K. (2007). Regulated expression by PPARalpha and unique localization of 17beta-hydroxysteroid dehydrogenase type 11 protein in mouse intestine and liver. FEBS J 274:4837–4847.
   PubMed Web of Science ®Google Scholar
• Zhang, M., Hu, P., Napoli, J. L. (2004). Elements in the N-terminal signaling sequence that determine cytosolic topology of short-chain dehydrogenases/reductases. Studies with retinol dehydrogenase type 1 and cis-retinol/androgen dehydrogenase type 1. J Biol Chem 279:51482–51489.
   Google Scholar